glp 1 agonist joint pain Glucagon-Like Peptide-1 Receptor Agonists in Osteoarthritis: From Clinical Promise to Preclinical Evidence How a discovery in joint
Description
Key Opinion Leader Views: Obesity experts stress these drugs do not cure the underlying disease, so weight regain often occurs if therapy stops
A Narrative Review for Clinical Practice
Newsome PN, Ambery P
sales of GLP-1 drugs were $13.7 billion
Sci Transl Med (2011) 3:77sr1
Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits hyperglycemia-induced apoptosis in myocytes by suppressing receptor for advanced glycation end products expression
